Overactive bladder

urge incontinencebladder spasmincontinenceoveractive bladder syndromebladder spasmsOABOver Active BladderUrge
Overactive bladder (OAB) is a condition where there is a frequent feeling of needing to urinate to a degree that it negatively affects a person's life.wikipedia
91 Related Articles

Urinary incontinence

incontinenceurinaryincontinent
If there is loss of bladder control then it is known as urge incontinence. More than 40% of people with overactive bladder have incontinence.
Urge incontinence due to an overactive bladder

Urination

urinateurinatingmicturition
Overactive bladder (OAB) is a condition where there is a frequent feeling of needing to urinate to a degree that it negatively affects a person's life.
Urge incontinence, incontinence that occurs as a result of the uncontrollable urge to urinate

Botulinum toxin

botoxbotulinumbotulin
Injections of botulinum toxin into the bladder is another option.
Botulinum toxin appears to be effective for refractory overactive bladder.

Nocturia

waking at night to urinatewaking up at night to urinateat night
The frequent need to urinate may occur during the day, at night, or both.
If the cause of nocturia is related to the obstruction of the prostate or an overactive bladder, surgical actions may be sought out.

Urinary urgency

urgencyfeeling the need to urinate right awayIncreased urgency of urination
Urgency is considered the hallmark symptom of OAB, but there are no clear criteria for what constitutes urgency and studies often use other criteria.
When uncontrollable, it is described as urge incontinence.

Hyoscine butylbromide

butylscopolamineBuscopanscopolamine
Such spasms can be controlled with medication such as butylscopolamine, although most patients eventually adjust to the irritation and the spasms go away.
Hyoscine butylbromide, also known as scopolamine butylbromide and sold under the brandname Buscopan among others, is a medication used to treat crampy abdominal pain, esophageal spasms, renal colic, and bladder spasms.

Bladder training

If treatment is desired pelvic floor exercises, bladder training, and other behavioral methods are initially recommended.
It is used as a first line treatment of overactive bladder on mixed urinary incontinence.

Urinary catheterization

urinary cathetercathetercatheterization
Urinary catheters or surgery are generally not recommended.
Males may have a slightly higher incidence of bladder spasms.

Benign prostatic hyperplasia

enlarged prostatebenign prostatic hypertrophybenign prostate hyperplasia
OAB causes similar symptoms to some other conditions such as urinary tract infection (UTI), bladder cancer, and benign prostatic hyperplasia (BPH).
Storage symptoms include the need to urinate frequently, waking at night to urinate, urgency (compelling need to void that cannot be deferred), involuntary urination, including involuntary urination at night, or urge incontinence (urine leak following a strong sudden need to urinate).

Cystoscopy

cystoscopecystourethroscopecystourethroscopy
Urodynamics, a bladder scope, and ultrasound are generally not needed.
loss of bladder control (incontinence) or overactive bladder; (Although, the American Urogynecologic Society does not recommend that cystoscopy, urodynamics, or diagnostic renal and bladder ultrasound are part of initial diagnosis for uncomplicated overactive bladder.)

Solifenacin

solifenacin succinate
A number of antimuscarinic drugs (e.g., darifenacin, hyoscyamine, oxybutynin, tolterodine, solifenacin, trospium, fesoterodine) are frequently used to treat overactive bladder.
Solifenacin (INN, trade name Vesicare) is a medicine of the antimuscarinic class and was developed for treating contraction of overactive bladder with associated problems such as increased urination frequency and urge incontinence.

Trospium chloride

trospium
A number of antimuscarinic drugs (e.g., darifenacin, hyoscyamine, oxybutynin, tolterodine, solifenacin, trospium, fesoterodine) are frequently used to treat overactive bladder.
Trospium chloride (INN) is used to treat overactive bladder.

Bladder cancer

bladderbladder carcinomacancer of the bladder
OAB causes similar symptoms to some other conditions such as urinary tract infection (UTI), bladder cancer, and benign prostatic hyperplasia (BPH).
Other possible symptoms include pain during urination (dysuria), frequent urination, or feeling the need to urinate without being able to do so. These signs and symptoms are not specific to bladder cancer, and may also be caused by non-cancerous conditions, including prostate infections, overactive bladder or cystitis.

Mirabegron

β3 adrenergic receptor agonists (e.g., mirabegron), may be used, as well.
Mirabegron (trade name Myrbetriq and Betmiga) is a medication for the treatment of overactive bladder.

Muscarinic antagonist

antimuscarinicanti-muscarinicmuscarinic antagonists
A number of antimuscarinic drugs (e.g., darifenacin, hyoscyamine, oxybutynin, tolterodine, solifenacin, trospium, fesoterodine) are frequently used to treat overactive bladder. Medications, typically of the anti-muscarinic type, are only recommended if other measures are not effective.

Percutaneous tibial nerve stimulation

Percutaneous tibial nerve stimulation (PTNS)posterior nervetranscutaneous tibial nerve stimulation
Various devices (Urgent PC Neuromodulation System) may also be used.
Percutaneous tibial nerve stimulation (PTNS), also referred to as posterior tibial nerve stimulation, is the least invasive form of neuromodulation used to treat overactive bladder (OAB) and the associated symptoms of urinary urgency, urinary frequency and urge incontinence.

Fesoterodine

fesoterodine fumarate
A number of antimuscarinic drugs (e.g., darifenacin, hyoscyamine, oxybutynin, tolterodine, solifenacin, trospium, fesoterodine) are frequently used to treat overactive bladder.
Fesoterodine (INN, used as the fumarate under the brand name Toviaz) is an antimuscarinic drug developed by Schwarz Pharma AG to treat overactive bladder syndrome (OAB).

National Association For Continence

National Association For Continence
General Audience: Bladder retraining, Urinary Catheterization of Men and Women, Fecal Incontinence, Incontinence and Odor Control, Overactive bladder

Underactive bladder

Underactive bladder
Overactive bladder

Constipation

constipatedobstipationchronic constipation
Risk factors include obesity, caffeine, and constipation.

Diabetes mellitus

diabetesdiabeticdiabetics
Poorly controlled diabetes, poor functional mobility, and chronic pelvic pain may worsen the symptoms.

Activities of daily living

daily livinginstrumental activities of daily livingADLs
Poorly controlled diabetes, poor functional mobility, and chronic pelvic pain may worsen the symptoms.

Pelvic pain

chronic pelvic painpain in the pelvic areapain in the pelvis
Poorly controlled diabetes, poor functional mobility, and chronic pelvic pain may worsen the symptoms.

Urinary tract infection

urinary tract infectionscystitisbladder infection
OAB causes similar symptoms to some other conditions such as urinary tract infection (UTI), bladder cancer, and benign prostatic hyperplasia (BPH). Diagnosis is based on a person's signs and symptoms and requires other problems such as urinary tract infections or neurological conditions to be excluded.

Neurogenic bladder dysfunction

neurogenic bladderbladder, neurogenicneurogenic bladder disturbance
Diagnosis is based on a person's signs and symptoms and requires other problems such as urinary tract infections or neurological conditions to be excluded.